Imaging agents:
Indications for: NEPHROSCAN
As an aid in the scintigraphic evaluation of renal parenchymal disorders.
Adult Dosage:
See full labeling. Give by IV inj (bolus). Administer 74–222MBq (2–6mCi). Begin image acquisition 1–4hrs post-inj. Severely reduced eGFR: delay image acquisition up to 6–24hrs.
Children Dosage:
See full labeling. Give by IV inj (bolus). Base dose on body wt. Administer 1.85MBq/kg (0.05mCi/kg) with a range of 19–74MBq (0.5–2mCi). Begin image acquisition 1–4hrs post-inj. Severely reduced eGFR: delay image acquisition up to 6–24hrs.
NEPHROSCAN Warnings/Precautions:
Risk of radiation exposure. Should only be used by trained and experienced physicians in the safe use and handling of radionuclides to minimize radiation exposure. Have resuscitation equipment/medications readily available. Ensure adequate hydration; encourage frequent voiding post-administration. Advanced renal failure: may have an effect on image interpretation. Elderly. Pregnancy. Nursing mothers: interrupt and pump/discard breastmilk for at least 24hrs after administration.
NEPHROSCAN Classification:
Radioactive diagnostic agent.
Adverse Reactions:
Urticaria, rash, pruritus, erythema, syncope, fever, nausea; hypersensitivity reactions.
Generic Drug Availability:
NO
How Supplied:
Kit—1 (5 single-dose vials)
